The Business Development team for the oncology division at one of the world’s largest pharmaceutical companies was spending too much time and money manually integrating multiple data types and sources, and still ending up with too many low-ROI opportunities.
As the amounts of potentially relevant external data sources expand, the team was being tasked to provide even more analytics support for its Search & Evaluation function. With limited human capital to take on these big data tasks, the company sought an advanced end-to-end analytics solution that could:
That’s where Signals Analytics made a huge impact.
Fill out the form to download your own our success story to learn more.